Reporting and Observation of ADR by Nurses in Hospitalized Patients

Abstract

The important topics of adverse drug reactions (ADRs) are covered in this article, with an emphasis on managing, preventing, and identifying them. ADRs are described as adverse or unexpected drug reactions, and because of their variable severity, they require a sophisticated understanding. While not necessarily dangerous, side effects have the potential to develop into ADRs, which calls for action. The decision-making process entails evaluating the severity of the adverse reaction, the drug's possible advantages, and the patient's overall risk-benefit profile. When it comes to tracking and reporting adverse drug reactions (ADRs) to regulatory bodies for continuous medication safety evaluation, healthcare practitioners are essential. The classification of adverse drug reactions (ADRs) and identification techniques, such as clinical symptoms, patient reporting, and pharmacovigilance systems, are also covered in the article. Acute therapy, early detection, and drug cessation are critical components of management strategies, especially in the case of anaphylaxis. A comprehensive strategy that includes patient assessment, provider communication, education, and the use of electronic health information is required to prevent ADRs. Continuous improvement of drug safety is facilitated by active participation in pharmacovigilance programs and stakeholder collaboration. To improve overall medication safety and efficacy, the article's conclusion highlights the shared objective of reducing ADR occurrence and impact.